Stage III verrucous carcinoma of the larynx
Showing 9976 - 10000 of >10,000
Anaplastic Medulloblastoma, Medulloblastoma Trial in Worldwide (drug, biological, other, radiation)
Active, not recruiting
- Anaplastic Medulloblastoma
- Medulloblastoma
- Carboplatin
- +8 more
-
Birmingham, Alabama
- +195 more
Jan 4, 2022
Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)
Completed
- Chronic Spontaneous Urticaria
- Ligelizumab
- +2 more
-
Birmingham, Alabama
- +182 more
Aug 5, 2022
Non Alcoholic Steatohepatitis Trial in Redwood City, Stanford (Idebenone, Placebo)
Recruiting
- Non Alcoholic Steatohepatitis
- Idebenone
- Placebo
-
Redwood City, California
- +1 more
Jul 16, 2021
Degenerative Arthritis Trial in West Palm Beach (Placebo, Ibuprofen modified release tablet 800 mg)
Recruiting
- Degenerative Arthritis
- Placebo
- Ibuprofen modified release tablet 800 mg
-
West Palm Beach, FloridaPalm Beach Research Center
Apr 13, 2022
Lupus Nephritis, Systemic Lupus Erythematosus Trial (Corticosteroids, Cyclophosphamide, Mycophenolate Mofetil)
Terminated
- Lupus Nephritis
- Systemic Lupus Erythematosus
- Corticosteroids
- +5 more
- (no location specified)
Nov 27, 2020
Adenoid Cystic Carcinoma of the Head and Neck Trial in Shanghai (All-trans Retinoic Acid, VEGFR inhibitor, Chemotherapy)
Recruiting
- Adenoid Cystic Carcinoma of the Head and Neck
- All-trans Retinoic Acid
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital
Jan 31, 2021
Cognition Disorders in Old Age, Lifestyle, Healthy, Diet, Healthy Trial (Healthy lifestyle)
Not yet recruiting
- Cognition Disorders in Old Age
- +3 more
- Healthy lifestyle
- (no location specified)
May 30, 2022
Real-world Evidence on Follitropin Delta Individual Dosing
Recruiting
- Infertility
- Sterility
- Follitropin delta
-
Luebeck, Schleswig-Holstein, GermanyUniversity of Luebeck
Jan 2, 2022
Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT
Terminated
- Head and Neck Neoplasms
-
Vila Nova De Gaia, PortugalCentro Hospitalar Vila Nova de Gaia / Espinho
Jul 31, 2021
Marijuana Abuse Trial in New York (3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition,
Recruiting
- Marijuana Abuse
- 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition
- 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fasting condition
-
New York, New YorkSubstance Use Research Center
Jan 25, 2023
Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)
Recruiting
- Nonsquamous Non-Small Cell Lung Cancer
- Sintilimab
- +3 more
-
Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
Nov 5, 2021
Colorectal Cancer Trial in Leeds, London, Cardiff (FOLFOX regimen, capecitabine, fluorouracil)
Completed
- Colorectal Cancer
- FOLFOX regimen
- +5 more
-
Leeds, England, United Kingdom
- +3 more
Sep 21, 2021
![](/image/sponsor/fondazione_cnrregione_toscana_"g_monasterio"_pisa_italy)
Kidney Failure, Chronic Trial in Worldwide (Extra-vascular lung water measurements by ultrasound (LW-US), Standard protocol of
Completed
- Kidney Failure, Chronic
- Extra-vascular lung water measurements by ultrasound (LW-US)
- Standard protocol of fluid management in hemodialysis
-
Bordeaux, France
- +18 more
May 4, 2021
Resistant Hypertension Trial (SAAE, traditional triple antihypertensive treatment)
Not yet recruiting
- Resistant Hypertension
- SAAE
- traditional triple antihypertensive treatment
- (no location specified)
Sep 20, 2022
Liposarcoma, Myxoid, Liposarcoma, Dedifferentiated, Liposarcoma, Round Cell Trial (Trabectedin, Pioglitazone Oral Product)
Not yet recruiting
- Liposarcoma, Myxoid
- +2 more
- Trabectedin
- Pioglitazone Oral Product
- (no location specified)
Mar 10, 2021
Breast Cancer, Hormone Receptor Positive Tumor Trial in Germany (3 weeks Dose Induction of Everolimus, 3 weeks Conventional
Completed
- Breast Cancer
- Hormone Receptor Positive Tumor
- 3 weeks Dose Induction of Everolimus
- +3 more
-
Neu Isenburg, Hessen, Germany
- +13 more
Feb 22, 2022
Patients With Hepatitis D Virus (HDV) Infection in China
Not yet recruiting
- Hepatitis D
-
Beijing, Beijing, ChinaBejing Tsinghua Changgung Hospital
Jul 7, 2022
Obesity, Metabolic Disease Trial in Santa Barbara (Behavioral plant-based dietary intervention, Standard care)
Not yet recruiting
- Obesity
- Metabolic Disease
- Behavioral plant-based dietary intervention
- Standard care
-
Santa Barbara, CaliforniaSansum Diabetes Research Institute
Sep 8, 2022
Ovarian Cancer, Peritoneal Cavity Cancer Trial in Dallas (Ad5CMV-p53 gene)
Completed
- Ovarian Cancer
- Peritoneal Cavity Cancer
- Ad5CMV-p53 gene
-
Dallas, TexasSimmons Cancer Center - Dallas
Jan 29, 2021
Overall Survival Trial in Qingdao (Anlotinib, PD-1 inhibitor)
Recruiting
- Overall Survival
- Anlotinib, PD-1 inhibitor
-
Qingdao, Shandong, China
- +1 more
Feb 23, 2022
CEUS Li-RADS in Hepatic Focal Lesions in Non-high Risk Factors
Recruiting
- Hepatocellular Carcinoma
- SonoVue
-
Beijing, Beijing, China
- +9 more
Jul 14, 2021
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (biological,
Completed
- Cervical Adenocarcinoma
- +7 more
- Filgrastim
- +4 more
-
Orange, California
- +77 more
Aug 6, 2019
Stage IV Pancreatic Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))
Terminated
- Stage IV Pancreatic Cancer
- Antineoplaston therapy (Atengenal + Astugenal)
-
Houston, TexasBurzynski Clinic
Dec 16, 2020
Post-operative Atrial Fibrillation in Patients Undergoing
Not yet recruiting
- Atrial Fibrillation
- +3 more
-
New Orleans, Louisiana
- +2 more
Apr 5, 2022